Navigation Links
Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
Date:2/5/2009

MELBOURNE, Australia, Feb.5 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has successfully concluded dose-escalation in its oral Phase I study for CYT997, the company's anticancer vascular-disrupting agent (VDA).

The primary objectives of this safety and tolerability study have been achieved. These were to determine the maximum tolerated dose (MTD) and the dose-limiting toxicities (DLTs) for the agent when administered orally in capsule form every two weeks to patients with a diverse range of solid tumors. Safety and tolerability data from this study augments data obtained in the company's first Phase I study where CYT997 was administered intravenously. Together, these studies suggest that the CYT997 is a potent and selective VDA which is well tolerated at biologically efficacious doses and is worthy of further investigation as a novel anticancer agent.

"Cytopia has now demonstrated the broad clinical potential of CYT997 in both intravenous and oral forms," said Mr. Andrew Macdonald, CEO. "The oral activity of CYT997 is a key advantage over most other vascular disrupting agents which are administered intravenously. The oral activity of the agent should markedly improve its clinical and commercial value."

The company has already commenced Phase II studies for the intravenous form of CYT997 and intends to undertake similar efficacy studies for the oral presentation. Investigating the safety and efficacy of metronomic dosing, frequent oral administration at a comparatively low, but biologically effective dose, is of particular interest.

This oral trial was partly funded under the company's $A3 million Commercial Ready grant.

Preliminary trial data

CYT997 was generally well tolerated in this study with a maximum tolerated dose in cancer patients of ca 165 mg/m2. This dose resulted in maximal plasma concentrations some twofold higher than those obse
'/>"/>

SOURCE Cytopia Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cytopia Scientific Presentations on JAK2 Inhibitor Program
2. Cytopia Commences Second Phase II Study in Brain Cancer
3. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
4. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
5. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
6. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
7. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
8. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
9. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
10. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
11. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research ... of the "Europe Fluoroscopy Market - Growth, Trends ... offering. The European market for Fluoroscopy is ... to 2020 Fluoroscopy is used to view ... catheter through blood vessels, bile ducts or the urinary ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ... the "Laboratory Centrifuges - Global Strategic Business ... Annual estimates and forecasts are provided for the ... analysis is provided for these markets. Market data ... research. Company profiles are primarily based on public ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/sn8mlw/picture_archiving ) has announced the ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... the period 2014 through 2020. Also, a seven-year historic analysis ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
... 2012 Lilly Diabetes today announced a donation of ... The contribution will support the Foundation,s mission to empower ... lives to the fullest. The Foundation will use the ... 1 diabetes as well as conference scholarships for families ...
... April 3, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... District Court for the District of Delaware has ruled ... 7,410,978 (the ,978 Patent), 7,759,359 (the ,359 Patent), 7,781,448 ... (the ,635 Patent) for Sanctura XR® (trospium chloride extended-release ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit 2
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers can ... person. , According to Psychology Today, humans are a curious ... that curiosity is a part of human development. People are ...
(Date:6/2/2015)... USA (PRWEB) June 02, 2015 Tronics, ... is deploying its growth strategy to benefit from the ... “In Yole Développement’s May 2015 Status of the MEMS ... grow sharply and reach $6.6B in 2020,” says Frederic ... Yole Développement . , The analyst adds that “although ...
(Date:6/2/2015)... October 1, 2015 the transition to ICD-10 will happen ... Monday, June 1st Congressman Kevin Brady, chairman of ... Committee, and 12 members of the Committee sent a ... the administration to provide a smooth transition for local ... newest coding system for healthcare professionals to code diseases, ...
(Date:6/2/2015)... 02, 2015 Erbelli’s Gourmet Pizzeria, Italian ... promote its handmade gourmet pizzas and calzones, fresh wraps, ... website is new, the recipes are not—they have been ... main feature of the site is the menu, which ... descriptions of all the items. You can order directly ...
(Date:6/2/2015)... Claflin Medical Equipment , a ... acquisition of RSI Equipment, Inc ., a ... 2015. , With CME’s recent merger of Hospital ... three premier organizations which specialize in the procurement and ... By combining forces, they now cover the entire country ...
Breaking Medicine News(10 mins):Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2
... soul, as the old adage goes, but scientists are reporting evidence ... basis for a long-sought test to detect infection with the agent ... disease from spreading in the food supply. A study on using ... Cow agent appears in ACS, semi-monthly journal Analytical Chemistry . ...
... fatigue is often a major problem for cancer ... completing therapy. Researchers at Mayo Clinic ( http://www.mayoclinic.org/oncology-rst/ ... ( http://ncctg.mayo.edu/ ) (NCCTG) recently completed a study ... and found that, while it did not improve ...
... ... advice to help you make the most out of this important event in your life. ... Richmond, VA (PRWEB) June 2, 2010 -- ... most popular month for weddings in the U.S. and getting married not only is one of ...
... 1, 2010 Middle-aged Canadians are much less worried about ... close to panic, says an Alberta researcher who has just ... differing attitudes today may foreshadow growing differences between the two ... McDaniel, a sociology researcher and demographics expert, has been working ...
... took ketorolac after mastectomy fared better, researchers say , ... woman takes after a mastectomy may influence the odds ... Researchers at the Catholic University of Louvain (Leuven) in ... cancer recurrence in 327 women from one to four ...
... ... ,Holy Grail, of cosmetic laser treatments for stretch marks and scars which could help up to ... (PRWEB) May 30, ... approved fractional laser treatment for stretch marks on the market, which promises to reduce the appearance ...
Cached Medicine News:Health News:Results from a study testing methylphenidate for cancer-related fatigue 2Health News:Results from a study testing methylphenidate for cancer-related fatigue 3Health News:A Good Night's Sleep Can Help Reduce June Wedding Planning Stress 2Health News:Survey highlights major Canada-US differences in people in middle age 2Health News:The Harley Medical group launches exclusive treatment for stretch marks and scars 2Health News:The Harley Medical group launches exclusive treatment for stretch marks and scars 3
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...
The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical micr...
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
The DEI 750 MD from Optronics is a surgical 3 CCD color microscope camera with a 10 meter head cable. Easily mounts on your microscopes C-mount adapter and is the best choice for your surgical imagin...
Medicine Products: